VEGFA and retinopathy of prematurity: In fact, anti-VEGF therapy has been widely used in current clinical applications, including ROP, wet AMD and PDR (Alon et al., 1995; Mintz-Hittner and Kuffel, 2008; Penn et al., 2008; Mintz-Hittner et al., 2011; Carroll and Owen, 2020).